Delivery Order SPE2DB20D3103-SPE2DB24FN7S7
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trodelvy 180 mg vials. The contract has a ceiling value of $6,389.72 and a performance period ending on May 22, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a completion date of August 7, 2025. The contract is a firm fixed-price delivery order, and it is not a set-aside contract. AmerisourceBergen Drug Corp has an Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TRODELVY 180 MG VIALS. The contract has a ceiling value of $6,007.00 and a period of performance ending on September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these specialized pharmaceutical products to support military treatment facilities and other federal healthcare programs. This delivery order is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $9,584.58, and a performance period ending on May 14, 2025. This contract is not a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a prescription medication. It is a firm fixed price contract with a ceiling value of $15,974.30 and a performance period ending on July 22, 2025. The contract is not set aside for any small business or socioeconomic program. AmerisourceBergen holds...
- This is a Firm Fixed Price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the procurement of TRODELVY 180 MG VIALS. The contract has a ceiling value of $6,389.72 and a period of performance through June 20, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a pharmaceutical product, with a firm fixed price ceiling value of $19,169.16 and a period of performance through June 3, 2025. The contract is not set-aside and was awarded on May 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,014 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 180 mg vials of the drug TRODELVY. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, with a ceiling value of $6,389.72 and a completion date of July 15, 2025. This is a firm fixed-price delivery order contract, which is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 180 mg vials of the drug Trodelvy. The $9,010.50 fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN7S7Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trodelvy 180 mg vials. The contract has a ceiling value of $36,042 and a performance period through June 3, 2024. It is a firm-fixed price contract type. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a significant vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, AmerisourceBergen plays a critical role in supplying essential medical commodities to various government agencies.